134 related articles for article (PubMed ID: 18439103)
1. TLR7 agonist 852A inhibition of tumor cell proliferation is dependent on plasmacytoid dendritic cells and type I IFN.
Inglefield JR; Dumitru CD; Alkan SS; Gibson SJ; Lipson KE; Tomai MA; Larson CJ; Vasilakos JP
J Interferon Cytokine Res; 2008 Apr; 28(4):253-63. PubMed ID: 18439103
[TBL] [Abstract][Full Text] [Related]
2. An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanoma.
Dummer R; Hauschild A; Becker JC; Grob JJ; Schadendorf D; Tebbs V; Skalsky J; Kaehler KC; Moosbauer S; Clark R; Meng TC; Urosevic M
Clin Cancer Res; 2008 Feb; 14(3):856-64. PubMed ID: 18245549
[TBL] [Abstract][Full Text] [Related]
3. First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer.
Dudek AZ; Yunis C; Harrison LI; Kumar S; Hawkinson R; Cooley S; Vasilakos JP; Gorski KS; Miller JS
Clin Cancer Res; 2007 Dec; 13(23):7119-25. PubMed ID: 18056192
[TBL] [Abstract][Full Text] [Related]
4. Comparison of human B cell activation by TLR7 and TLR9 agonists.
Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation.
Kemp TJ; Elzey BD; Griffith TS
J Immunol; 2003 Jul; 171(1):212-8. PubMed ID: 12817000
[TBL] [Abstract][Full Text] [Related]
6. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity.
Kalb ML; Glaser A; Stary G; Koszik F; Stingl G
J Immunol; 2012 Feb; 188(4):1583-91. PubMed ID: 22231699
[TBL] [Abstract][Full Text] [Related]
7. IFN-β Therapy Regulates TLR7-Mediated Response in Plasmacytoid Dendritic Cells of Multiple Sclerosis Patients Influencing an Anti-Inflammatory Status.
Severa M; Rizzo F; Giacomini E; Annibali V; Gafa V; Romano S; Buscarinu MC; Fornasiero A; Salvetti M; Coccia EM
J Interferon Cytokine Res; 2015 Sep; 35(9):668-81. PubMed ID: 25923141
[TBL] [Abstract][Full Text] [Related]
8. Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells.
Petzke MM; Brooks A; Krupna MA; Mordue D; Schwartz I
J Immunol; 2009 Oct; 183(8):5279-92. PubMed ID: 19794067
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.
Gibson SJ; Lindh JM; Riter TR; Gleason RM; Rogers LM; Fuller AE; Oesterich JL; Gorden KB; Qiu X; McKane SW; Noelle RJ; Miller RL; Kedl RM; Fitzgerald-Bocarsly P; Tomai MA; Vasilakos JP
Cell Immunol; 2002; 218(1-2):74-86. PubMed ID: 12470615
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists.
Rajagopal D; Paturel C; Morel Y; Uematsu S; Akira S; Diebold SS
Blood; 2010 Mar; 115(10):1949-57. PubMed ID: 20065291
[TBL] [Abstract][Full Text] [Related]
11. The TLR7 ligand 9-benzyl-2-butoxy-8-hydroxy adenine inhibits IL-17 response by eliciting IL-10 and IL-10-inducing cytokines.
Vultaggio A; Nencini F; Pratesi S; Maggi L; Guarna A; Annunziato F; Romagnani S; Parronchi P; Maggi E
J Immunol; 2011 Apr; 186(8):4707-15. PubMed ID: 21389257
[TBL] [Abstract][Full Text] [Related]
12. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
[TBL] [Abstract][Full Text] [Related]
13. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
[TBL] [Abstract][Full Text] [Related]
14. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
Elner VM; Burnstine MA; Strieter RM; Kunkel SL; Elner SG
Exp Eye Res; 1997 Dec; 65(6):781-9. PubMed ID: 9441701
[TBL] [Abstract][Full Text] [Related]
15. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
[TBL] [Abstract][Full Text] [Related]
16. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
[TBL] [Abstract][Full Text] [Related]
17. S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells.
Dillmann C; Ringel C; Ringleb J; Mora J; Olesch C; Fink AF; Roberts E; Brüne B; Weigert A
J Immunol; 2016 Feb; 196(4):1579-90. PubMed ID: 26783340
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells.
Sisirak V; Vey N; Goutagny N; Renaudineau S; Malfroy M; Thys S; Treilleux I; Labidi-Galy SI; Bachelot T; Dezutter-Dambuyant C; Ménétrier-Caux C; Blay JY; Caux C; Bendriss-Vermare N
Int J Cancer; 2013 Aug; 133(3):771-8. PubMed ID: 23389942
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
20. TLR7 stimulation of APCs results in inhibition of IL-5 through type I IFN and Notch signaling pathways in human peripheral blood mononuclear cells.
Edwards S; Jones C; Leishman AJ; Young BW; Matsui H; Tomizawa H; Murray CM; Biffen M
J Immunol; 2013 Mar; 190(6):2585-92. PubMed ID: 23382558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
